Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Melatonin reduces oxidative neurotoxicity due to quinolinic acid: In vitroand in vivo findings
Autore:
Cabrera, J; Reiter, RJ; Tan, DX; Qi, WB; Sainz, RM; Mayo, JC; Garcia, JJ; Kim, SJ; El-Sokkary, G;
Indirizzi:
Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA Univ Texas San Antonio TX USA 78284 truct Biol, San Antonio, TX 78284 USA Univ Las Palmas Gran Canaria, Dept Farmacol, Fac Med, Las Palmas Gran Canaria, Spain Univ Las Palmas Gran Canaria Las Palmas Gran Canaria Spain naria, Spain
Titolo Testata:
NEUROPHARMACOLOGY
fascicolo: 3, volume: 39, anno: 2000,
pagine: 507 - 514
SICI:
0028-3908(2000)39:3<507:MRONDT>2.0.ZU;2-F
Fonte:
ISI
Lingua:
ENG
Soggetto:
INDUCED LIPID-PEROXIDATION; FREE-RADICAL PRODUCTION; NITRIC-OXIDE SYNTHASE; KYNURENINE PATHWAY; INDUCED SEIZURES; BRAIN-REGIONS; RAT; NEURONS; DAMAGE; MICE;
Keywords:
melatonin; quinolinic acid; lipid peroxidation; neurotoxicity; free radicals; brain;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Life Sciences
Citazioni:
69
Recensione:
Indirizzi per estratti:
Indirizzo: Reiter, RJ Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, 7703 Floyd Curl Dr,San Antonio, TX 78284 USA Univ Texas 7703 Floyd Curl Dr San Antonio TX USA 78284 8284 USA
Citazione:
J. Cabrera et al., "Melatonin reduces oxidative neurotoxicity due to quinolinic acid: In vitroand in vivo findings", NEUROPHARM, 39(3), 2000, pp. 507-514

Abstract

The in vivo and in vitro effects of melatonin on quinolinic acid-induced oxidative damage in rat brain were determined. The concentrations of malonaldehyde and 4-hydroxyalkenals were assayed as an index of oxidatively damaged lipid. In in vitro experiments, the increase in malonaldehyde and 4-hydroxyalkenals concentrations induced by quinolinic acid were concentration-dependent and time-dependent. The accumulation of products of lipid peroxidation induced by quinolinic acid were very significantly reduced by melatonin in a concentration-dependent manner. Additionally, at the highest concentrations of melatonin used in quinolinic acid treated homogenates, it reduced the levels of oxidatively damaged lipid products below those measured in control homogenates (no quinolinic acid or melatonin). When quinolinic acid (200 mg/kg) was intraperitonally injected into Ii-day-old rats, lipid peroxidation in the brain was significantly increased 24 hours later compared to levels in control rats. When melatonin (10 mg/kg) was injected ip 30 min before and 4 and 20 hours after the administration of quinolinic acid, the increased lipid peroxidation induced by quinolinic acid was significantly reduced. Likewise, neurobehavioral signs associated with quinolinate administration were attenuated by melatonin. These results show that both in vitro and in vivo pharmacological levels of melatonin confer protection against quinolinic acid-induced oxidative toxicity in the brain. The findings also indicate that melatonin may be pharmacologically useful in combatting quinolinic neurotoxicity which is associated with several acute and chronic neurodegenerative neurological diseases. (C) 2000 Elsevier science Ltd. All rights reserved.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/09/20 alle ore 13:49:00